E. Akaho. “Development of Cyclic Tetrapeptide As an EGFR Tyrosine Kinase Inhibitor Assayed by ELISA Experiment and Docking Study: A Novel Approach”. Challenges and Advances in Pharmaceutical Research Vol. 2, Apr. 2022, pp. 108-21, doi:10.9734/bpi/capr/v2/1757A.